Neural stem cells healing a damaged brain.

Can Stem Cells Heal the Brain? New Hope for Traumatic Brain Injury

Rhea Morgan in Health & Wellness November 2025 • 4 min read.

"Pioneering research explores how induced pluripotent stem cells (iPSCs) could revolutionize traumatic brain injury (TBI) treatment and neural repair."

Traumatic brain injury (TBI) is a significant global health issue, affecting millions each year. TBI can lead to long-term disabilities, placing immense strain on individuals, families, and healthcare systems. Current treatments often focus on managing symptoms and providing supportive care, but the need for regenerative therapies is clear.

Stem cell therapy has emerged as a promising avenue for addressing the underlying damage caused by TBI. Among the different types of stem cells, induced pluripotent stem cells (iPSCs) hold particular promise. These cells, derived from adult cells, can be reprogrammed to become any cell type in the body, offering a versatile tool for repairing damaged brain tissue.

A recent study published in Cell Transplantation has explored the potential of iPSCs in treating TBI in rats. The research focuses on tracking iPSCs as they are introduced into the brain, providing valuable insights into their behavior and therapeutic effects. The study sheds light on the possibilities of stem cell-based therapies for TBI, offering hope for improved outcomes and neural regeneration.

The Science Behind iPSCs: How Stem Cells are Revolutionizing Brain Injury Treatment

Neural stem cells healing a damaged brain.

The study, led by researchers at Fudan University in Shanghai, investigated how iPSCs could aid in the reconstruction of brain tissue and restoration of brain function after TBI. The researchers derived iPSCs from skin fibroblasts using four key factors: Oct4, Sox2, Myc, and Klf4. These iPSCs were then differentiated into neural stem cells (NSCs), which have the ability to develop into various types of brain cells.

To track the NSCs within the brain, the scientists used superparamagnetic iron oxide particles (SPIOs). These particles acted as markers, allowing the NSCs to be visible during magnetic resonance imaging (MRI). The NSCs were incubated with SPIOs in vitro, ensuring that the cells were effectively labeled before transplantation.

iPSC Derivation: Successfully derived iPSCs from skin fibroblasts using Oct4, Sox2, Myc, and Klf4.
NSC Differentiation: Induced iPSCs to differentiate into NSCs, expressing Nestin and capable of becoming neural and glial cells.
SPIO Labeling: Labeled NSCs with SPIOs overnight, confirmed by Prussian blue staining showing intracellular particles.
MRI Tracking: T2-weighted MRI showed NSCs migrated to the injury area post-implantation.
Functional Detection: Manganese-enhanced MRI (ME-MRI) detected NSCs function, which diltiazem could block.

The rat models of TBI were divided into three groups: two groups received NSCs labeled with SPIOs, and one group received non-labeled NSCs. MRI scans were performed over several weeks to monitor the distribution of the NSCs. The study also used manganese-enhanced MRI (ME-MRI) to assess the function of the transplanted NSCs. Diltiazem, a calcium channel blocker, was used to investigate whether the NSCs' activity could be modulated.

Looking Ahead: The Future of Stem Cell Therapies for TBI

This study provides compelling evidence that iPSC-derived NSCs can be successfully tracked in the brain using MRI. The ability to monitor the migration and function of these cells opens up new avenues for understanding and treating TBI. While further research is needed, the findings suggest that stem cell-based therapies hold great potential for improving outcomes and promoting neural regeneration in patients with TBI.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1177/0963689718819994, Alternate LINK

Title: Mri Tracking Of Ips Cells-Induced Neural Stem Cells In Traumatic Brain Injury Rats

Subject: Transplantation

Journal: Cell Transplantation

Publisher: SAGE Publications

Authors: Lili Jiang, Ronggang Li, Hailiang Tang, Junjie Zhong, Huaping Sun, Weijun Tang, Huijuan Wang, Jianhong Zhu

Published: 2018-12-21

Everything You Need To Know

What exactly are induced pluripotent stem cells (iPSCs), and why are they particularly promising for treating traumatic brain injury (TBI)?

Induced pluripotent stem cells, or iPSCs, are adult cells reprogrammed to become any cell type. In the context of traumatic brain injury, iPSCs can differentiate into neural stem cells (NSCs) capable of repairing damaged brain tissue. The advantage of using iPSCs is their versatility in becoming various types of brain cells needed for regeneration.

How did the scientists track the induced pluripotent stem cells (iPSCs) after they were introduced into the brains of the rats with traumatic brain injury (TBI)?

Researchers tracked the induced pluripotent stem cells (iPSCs) using superparamagnetic iron oxide particles (SPIOs). These particles acted as markers, allowing the neural stem cells (NSCs) to be visible during magnetic resonance imaging (MRI). This method enables scientists to monitor the migration and distribution of the transplanted cells within the brain over time.

What is the role of manganese-enhanced MRI (ME-MRI) in assessing the function of transplanted neural stem cells (NSCs) and how was diltiazem used in the study?

Manganese-enhanced MRI (ME-MRI) assesses the function of transplanted neural stem cells (NSCs). The study modulated NSC activity using diltiazem, a calcium channel blocker, to investigate the functional impact. This is significant because it allows researchers to understand not only where the cells migrate, but also whether they are actively contributing to neural repair and regeneration.

Which specific factors were used in the Fudan University study to derive induced pluripotent stem cells (iPSCs) from skin fibroblasts?

The Fudan University study used Oct4, Sox2, Myc, and Klf4 to derive induced pluripotent stem cells (iPSCs) from skin fibroblasts. These factors are essential for reprogramming adult cells into a pluripotent state. This is a crucial step in creating versatile stem cells capable of differentiating into neural stem cells (NSCs) for brain repair.

What are some of the key next steps or areas needing further research to translate these findings on induced pluripotent stem cells (iPSCs) into effective therapies for traumatic brain injury (TBI)?

The study highlights the potential of induced pluripotent stem cells (iPSCs) for treating traumatic brain injury (TBI), but several aspects require further investigation. For example, understanding the long-term effects of iPSC-derived neural stem cells (NSCs) and optimizing the differentiation protocols to ensure the generation of specific types of brain cells are vital. Additionally, addressing potential immune responses and developing methods for targeted delivery of cells to the injury site are key challenges for future research.